Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2007
12/26/2007CN101094846A 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists
12/26/2007CN101094841A Indinavir derivatives useful in immunoassay
12/26/2007CN101094837A Novel beta agonists, method for producing the same and their use as drugs
12/26/2007CN101094836A Methods for preparing indazole compounds
12/26/2007CN101094835A Novel dicarboxamide derivatives
12/26/2007CN101094834A Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
12/26/2007CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors
12/26/2007CN101092342A Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds
12/26/2007CN101091923A Carbon nitrogen coupling reaction catalyst composed of heterocycle functional group 1,3 diketone and halogenated univalence copper, and preparation method
12/26/2007CN100357278C Substituted triazole diamine derivatives as kinase inhibitors
12/26/2007CN100357277C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
12/26/2007CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
12/26/2007CN100357273C Process for the production of substituted nicotinic acid esters
12/26/2007CN100357270C D-proline derivative
12/26/2007CN100356979C Integrin expression inhibitors
12/25/2007US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
12/25/2007US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically
12/25/2007US7312333 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease
12/25/2007US7312332 Such as 1-butyl-3-hydroxy-1-[2-hydroxy-3-(1-oxyl-2,2,6,6-tetramethyl-piperidin-4-yloxy)-propyl]-azetidinium chloride; yellowing and discoloration prevention; ultraviolet, fluorescent and solar light stability; expanding use of high yield pulps to higher grade products
12/25/2007US7312235 Anticoagulants
12/25/2007US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007US7312229 21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators
12/25/2007US7312227 Autoimmune diseases; Alzheimer's disease; Parkinson's disease; bone disorders; liver disorders; rheumatic disease; amythrophiic lateral sclerosis
12/25/2007US7312222 Heterocyclic piperidines as modulators of chemokine receptor activity
12/25/2007US7312221 Therapeutic treatment of endotoxic shock with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating psoriasis, arthritis, osteoarthritis, glomerulonephriti, autoimmune disorder include diabetes, asthma, or multiple sclerosis
12/25/2007US7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/25/2007US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide
12/25/2007US7312216 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide methanesulfonate; antiproliferative agent
12/25/2007US7312214 Anticoagulants; atherosclerosis; strokes; thrombosis; cardiovascular disorders
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007US7312180 Substituted 4-(4-trifluoromethylpyrazolyl)pyrimidines
12/25/2007US7311736 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds
12/21/2007WO2007146981A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
12/21/2007WO2007146977A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007WO2007146225A2 Heterocyclic aspartyl protease inhibitors
12/21/2007WO2007146202A2 Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
12/21/2007WO2007146116A2 Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
12/21/2007WO2007146072A2 Process for synthesizing piperazine-piperidine compounds
12/21/2007WO2007146066A2 Novel piperazines, pharmaceutical compositions and methods of use thereof
12/21/2007WO2007145563A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007WO2007145282A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007WO2007144579A1 N-oxides of diarylurea derivatives and their use as chk1 inhibitors for the treatment of cancer
12/21/2007WO2007144127A1 Pyrrole derivatives with crth2 receptor modulator activity
12/21/2007WO2007144100A1 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
12/21/2007WO2007143822A1 Sulfamide and sulfamate derivatives as histone deacetylase inhibitors
12/21/2007WO2007127688A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/21/2007WO2007126964A3 Kinase inhibitors
12/21/2007WO2007117607A3 Quinazolines for pdk1 inhibition
12/21/2007WO2007112913A3 Benzimidazole derivatives
12/21/2007WO2007110835A3 A coupling process for preparing quinolone intermediates
12/21/2007WO2007105058A3 Pyrazole compounds
12/21/2007WO2007099509A3 Primary amines as renin inhibitors
12/21/2007WO2007093529A3 Heteroaroyl-substituted alanines
12/21/2007WO2007063418A3 Substituted indole compounds having nos inhibitory activity
12/21/2007WO2007062078A3 Thrombopoietin activity modulating compounds and methods
12/21/2007WO2007059359A3 Substituted pyrazalones
12/21/2007WO2005051366A3 Diaryl urea derivatives in the treatment of protein kinase dependent diseases
12/21/2007CA2659512A1 Novel piperazines, pharmaceutical compositions and methods of use thereof
12/21/2007CA2655315A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007CA2655286A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007CA2654927A1 Substituted phenyl acetic acids as dp-2 antagonists
12/21/2007CA2654515A1 Substituted 3-cyanopyridines as protein kinase inhibitors
12/21/2007CA2654327A1 Pyrrole derivatives with crth2 receptor modulator activity
12/21/2007CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007CA2653777A1 2-anilino-4-(heterocyclic)amino-pyrimidines
12/21/2007CA2653686A1 Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
12/21/2007CA2653682A1 Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
12/21/2007CA2653679A1 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
12/21/2007CA2653650A1 Heterocyclic aspartyl protease inhibitors
12/21/2007CA2653039A1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
12/21/2007CA2650934A1 Processes for synthesizing piperazine-piperidine compounds
12/21/2007CA2650666A1 Substituted cyanopyridines as protein kinase inhibitors
12/20/2007US20070293683 N-phenyl-2-pyrimidine-amine derivatives
12/20/2007US20070293682 Methods of Preparing Sulfinamides and Sulfoxides
12/20/2007US20070293680 For the preparation of (R)-(+)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl) methyl]-4-(3-chlorophenyl)-1-methyl2(1H)-quinolinone; farnesyl tranferase inhibitory activity
12/20/2007US20070293679 Diastereoselective Addition of Lithiated N-Methylimidazole on Sulfinimines
12/20/2007US20070293673 N-phenyl-2-pyrimidine-amine derivatives
12/20/2007US20070293672 N-phenyl-2-pyrimidine-amine derivatives
12/20/2007US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia
12/20/2007US20070293543 THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z
12/20/2007US20070293541 CB1 cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders
12/20/2007US20070293534 Process for the preparation of mivacurium chloride
12/20/2007US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade
12/20/2007US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293522 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293520 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293519 Analogs of thalidomide as potential angiogenesis inhibitors
12/20/2007US20070293517 Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety
12/20/2007US20070293507 Pyrazole Kinase Modulators And Methods Of Use
12/20/2007US20070293504 N-phenyl-2-pyrimidine-amine derivatives
12/20/2007US20070293501 Thioalkeneamides as Transketolase Inhibitors
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same
12/20/2007US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
12/20/2007US20070293490 Quinazoline Derivatives
12/20/2007US20070293486 Alpha-Keto Carbonyl Calpain Inhibitors
12/20/2007US20070293478 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses
12/20/2007US20070293472 Novel 14 and 15 Membered Ring Compounds
12/20/2007US20070293455 Silylated Carboxamides
1 ... 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 ... 1080